Evidence map›Paper›PMID 21166923›Full record

ArticleMicrocirculation (New York, N.Y. : 1994)2011

Substance P activates both contractile and inflammatory pathways in lymphatics through the neurokinin receptors NK1R and NK3R.

Sanjukta Chakraborty, Zhanna Nepiyushchikh, Michael J Davis, David C Zawieja, Mariappan Muthuchamy

Abstract read
In one paragraph

Article in Microcirculation (New York, N.Y. : 1994), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neuroimmune interplay in kidney health and disease: Role of renal nerves.Autonomic neuroscience : basic & clinical · 2023
    Review
  7. Mechanisms of Transmission and Processing of Pain: A Narrative Review.International journal of environmental research and public health · 2023
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Evidence of functional ryanodine receptors in rat mesenteric collecting lymphatic vessels.American journal of physiology. Heart and circulatory physiology · 2019
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Substance P Inhibits the Collagen Synthesis of Rat Myocardial Fibroblasts Induced by Ang II.Medical science monitor : international medical journal of experimental and clinical research · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sanjukta ChakrabortyDivision of Lymphatic Biology, Department of Systems Biology and Translational Medicine, Cardiovascular Research Institute, Texas A&M Health Science Center College of Medicine, College Station, Texas 77843, USA.
Zhanna Nepiyushchikh
Michael J Davis
David C Zawieja
Mariappan Muthuchamy
Texas A&M Health Science Center · USUniversity of Missouri · US

Funding

Influences of Lymph Flow on the Lymphatic PumpR01HL070308 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI ZAWIEJA, DAVID CARL · 2003 to 2010
$2.4M
Molecular Mechanisms of Lymphatic Muscle ContractionR01HL080526 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MUTHUCHAMY, MARIAPPAN · 2005 to 2009
$1.7M
Cellular Mechanisms of Lymphatic Muscle ContractilityR01HL089784 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DAVIS, MICHAEL JOHN · 2008 to 2012
$1.7M
Regulatory Mechanisms in Lymphatic Muscle ContractionK02HL086650 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI MUTHUCHAMY, MARIAPPAN · 2007 to 2011
$502k
NHLBI NIH HHS K02 HL086650NHLBI NIH HHS KO2 HL086650NHLBI NIH HHS R01 HL070308NHLBI NIH HHS R01HL070308NHLBI NIH HHS R01 HL080526NHLBI NIH HHS R01 HL089784
6 · The paper itself

Abstract

objectiveThe aim of this study was to elucidate the molecular signaling mechanisms by which substance P (SP) modulates lymphatic muscle contraction and to determine whether SP stimulates both contractile as well as inflammatory pathways in the lymphatics.

methodsA rat mesenteric lymphatic muscle cell culture model (RMLMCs) and known specific pharmacological inhibitors were utilized to delineate SP-mediated signaling pathways in lymphatics.

resultsWe detected expression of neurokinin receptor 1 (NK1R) and neurokinin receptor 3 (NK3R) in RMLMCs. SP stimulation increased phosphorylation of myosin light chain 20 (MLC₂₀) as well as p38 mitogen associated protein kinase (p38-MAPK) and extracellular signal regulated kinase (ERK1/2) indicating activation of both a contractile and a pro-inflammatory MAPK pathway. Pharmacological inhibition of both NK1R and NK3R significantly affected the downstream SP signaling. We further examined whether there was any crosstalk between the two pathways upon SP stimulation. Inhibition of ERK1/2 decreased levels of p-MLC₂₀ after SP activation, in a PKC dependent manner, indicating a potential crosstalk between these two pathways.

conclusionsThese data provide the first evidence that SP-mediated crosstalk between pro-inflammatory and contractile signaling mechanisms exists in the lymphatic system and may be an important bridge between lymphatic function modulation and inflammation.

Indexed as

AnimalsCells, CulturedInflammationLymphatic VesselsMaleMitogen-Activated Protein Kinase 3Muscle ContractionMuscle, Smooth, VascularMyocytes, Smooth MuscleMyosin Light ChainsNeurotransmitter Agentsp38 Mitogen-Activated Protein KinasesPhosphorylationRatsRats, Sprague-DawleyReceptors, Neurokinin-1Mitogen-Activated Protein Kinase 3Myosin Light ChainsNeurotransmitter Agentsp38 Mitogen-Activated Protein KinasesReceptors, Neurokinin-1Receptors, Neurokinin-3Substance P

Identifiers

PMID21166923
PMCPMC3058475
OpenAlexW1620827315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.